Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma
Cancer Letters · 2024-11 · 604 · 217272
DOI: 10.1016/j.canlet.2024.217272 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2024-11. Verfasst von Shujie Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of …. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Tumor Microenvironment, Lung Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 127 Literaturangaben.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) have profoundly reshaped the treatment paradigm for non-small cell lung cancer (NSCLC). Despite these advancements, primary and secondary resistance to ICIs remain prevalent challenges in managing advanced NSCLC. Recent studies have highlighted the significant role of the tumor microenvironment (TME) in modulating treatment responses. This review aims to comprehensively examine the interactive roles of immune/stromal cells-such as T cells, B cells, neutrophils, macrophages, and CAFs within the TME, elucidating how these diverse cellular interactions contribute to immunotherapy resistance. It focuses on the dynamic interactions among diverse cell types such as the varying states of T cells under the influence of TME constituents like immune cells and cancer-associated fibroblasts (CAFs). By exploring the mechanisms involved in the complex cellular interactions, we highlight novel therapeutic targets and strategies aimed at overcoming resistance, thereby enhancing the efficacy of ICIs in NSCLC. Our synthesis of recent research provides critical insights into the multifaceted mechanisms of resistance and paves the way for the development of more effective, personalized treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
- Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, China.
- MOE Key Laboratory of Environment and Genes Related to Diseases, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, 710061, China.
- Department of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong; Peter Hung Pain Research Institute, The…
Zitieren
APA
Huang, S., Chung, J. Y., Li, C., Wu, Y., Qiao, G., To, K. F., & Tang, P. M. (2024). Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma. Cancer Letters, 604, 217272. https://doi.org/10.1016/j.canlet.2024.217272
Vancouver
Huang S, Chung JY, Li C, Wu Y, Qiao G, To KF, et al. Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma. Cancer Letters. 2024;604:217272. doi:10.1016/j.canlet.2024.217272
BibTeX
@article{Huang2024,
author = {Huang, Shujie and Chung, Jeff Yat-Fai and Li, Chunjie and Wu, Yi and Qiao, Guibin and To, Ka-Fai and Tang, Patrick Ming-Kuen},
title = {Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma},
journal = {Cancer Letters},
year = {2024},
volume = {604},
pages = {217272},
doi = {10.1016/j.canlet.2024.217272}
}
EUVIMED